Digital Health News | pharmaphorum

News

Top podcaster spread health misinformation, claims BBC probe

Prominent podcaster Steven Bartlett has been accused of allowing health misinformation to be shared on his Diary of a CEO stream.

News

Ro co-founder and chief executive Zach Reitano

Lilly adds another sales channel for obesity drug Zepbound

Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel.

News

Mulvany hits the reset button at BenevolentAI

The shape of BenevolentAI following the return of co-founder Ken Mulvany has started to crystallise and could see the company return to private hands.

News

Drug-digital dual therapy for depression starts phase 2

Gate Neurosciences' antidepressant apimostinel has started a proof-of-concept study to see if its efficacy can be boosted by a digital training tool.

News

Insulin pump firm Insulet wins $452m in trade secrets clash

Insulet is celebrating a jury's verdict that rival South Korean firm EOFlow stole trade secrets relating to its wearable insulin pump technology.

News

Orexo exits depression DTx alliance with GAIA

Four years after buying US rights to GAIA's digital therapeutic to help people with depression, Swedish drugmaker Orexo has terminated the deal.

Top podcaster spread health misinformation, claims BBC probe

Lilly adds another sales channel for obesity drug Zepbound

Mulvany hits the reset button at BenevolentAI

Drug-digital dual therapy for depression starts phase 2

Insulin pump firm Insulet wins $452m in trade secrets clash

Orexo exits depression DTx alliance with GAIA

US pharma tariffs of up to 100% finalised by Trump

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks